213 related articles for article (PubMed ID: 35743581)
1. Locally Recurrent Rectal Cancer According to a Standardized MRI Classification System: A Systematic Review of the Literature.
Rokan Z; Simillis C; Kontovounisios C; Moran B; Tekkis P; Brown G
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743581
[TBL] [Abstract][Full Text] [Related]
2. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.
Denost Q; Saillour F; Masya L; Martinaud HM; Guillon S; Kret M; Rullier E; Quintard B; Solomon M
BMC Cancer; 2016 Apr; 16():262. PubMed ID: 27044252
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of classification systems for locally recurrent rectal cancer.
Rokan Z; Simillis C; Kontovounisios C; Moran BJ; Tekkis P; Brown G
BJS Open; 2021 May; 5(3):. PubMed ID: 33963369
[TBL] [Abstract][Full Text] [Related]
4. Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.
Detering R; Karthaus EG; Borstlap WAA; Marijnen CAM; van de Velde CJH; Bemelman WA; Beets GL; Tanis PJ; Aalbers AGJ;
Eur J Surg Oncol; 2019 Nov; 45(11):2059-2069. PubMed ID: 31230980
[TBL] [Abstract][Full Text] [Related]
5. A phase III randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as preoperative treatment for locally recurrent rectal cancer - GRECCAR 15 trial protocol.
Denost Q; Frison E; Salut C; Sitta R; Rullier A; Harji D; Maillou-Martinaud H; Rullier E; Smith D; Vendrely V;
Colorectal Dis; 2021 Jul; 23(7):1909-1918. PubMed ID: 33843133
[TBL] [Abstract][Full Text] [Related]
6. Beyond Total Mesorectal Excision (TME)-Results of MRI-Guided Multivisceral Resections in T4 Rectal Carcinoma and Local Recurrence.
Stelzner S; Kittner T; Schneider M; Schuster F; Grebe M; Puffer E; Sims A; Mees ST
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001587
[TBL] [Abstract][Full Text] [Related]
7. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
[TBL] [Abstract][Full Text] [Related]
8. [Current surgical strategy of locally recurrent rectal cancer].
Wang X; Jiang Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jul; 20(7):748-752. PubMed ID: 28722086
[TBL] [Abstract][Full Text] [Related]
9. Prediction of R0/R+ surgery by different classifications for locally recurrent rectal cancer.
Sorrentino L; Belli F; Guaglio M; Daveri E; Cosimelli M
Updates Surg; 2021 Apr; 73(2):539-545. PubMed ID: 33555570
[TBL] [Abstract][Full Text] [Related]
10. Implementation of an Enhanced Recovery after Surgery Protocol in Advanced and Recurrent Rectal Cancer Patients after beyond Total Mesorectal Excision Surgery: A Feasibility Study.
Nordkamp S; Creemers DMJ; Glazemakers S; Ketelaers SHJ; Scholten HJ; van de Calseijde S; Nieuwenhuijzen GAP; Tolenaar JL; Crezee HW; Rutten HJT; Burger JWA; Bloemen JG
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760492
[TBL] [Abstract][Full Text] [Related]
11. Robotic-assisted resection for beyond TME rectal cancer: a novel classification and analysis from a specialized center.
Piozzi GN; Lee TH; Kwak JM; Kim J; Kim SH
Updates Surg; 2021 Jun; 73(3):1103-1114. PubMed ID: 33068271
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment MRI in Primary Rectal Cancer as a Predictor for Oncological Outcomes After Surgery for Local Recurrence.
Elliot AH; Othman BN; Suzuki C; Blomqvist L; Martling A; Johansson H; Glimelius B; Nilsson PJ; Iversen H
Anticancer Res; 2021 May; 41(5):2459-2465. PubMed ID: 33952471
[TBL] [Abstract][Full Text] [Related]
13. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
[No Abstract] [Full Text] [Related]
14. Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement.
Mariathasan AB; Boye K; Giercksky KE; Brennhovd B; Gullestad HP; Emblemsvåg HL; Grøholt KK; Dueland S; Flatmark K; Larsen SG
Eur J Surg Oncol; 2018 Aug; 44(8):1226-1232. PubMed ID: 29691115
[TBL] [Abstract][Full Text] [Related]
15. International variation in managing locally advanced or recurrent rectal cancer: prospective benchmark analysis.
Denost Q; Solomon M; Tuech JJ; Ghouti L; Cotte E; Panis Y; Lelong B; Rouanet P; Faucheron JL; Jafari M; Lefevre JH; Rullier E; Heriot A; Austin K; Lee P; Brown W; Maillou-Martinaud H; Savel H; Quintard B; Broc G; Saillour-Glénisson F
Br J Surg; 2020 Dec; 107(13):1846-1854. PubMed ID: 32786027
[TBL] [Abstract][Full Text] [Related]
16. Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer.
Westberg K; Palmer G; Hjern F; Holm T; Martling A
Br J Surg; 2019 May; 106(6):790-798. PubMed ID: 30776087
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant (re)chemoradiation for locally recurrent rectal cancer: Impact of anatomical site of pelvic recurrence on long-term results.
Sorrentino L; Belli F; Valvo F; Villa S; Guaglio M; Scaramuzza D; Gronchi A; Di Bartolomeo M; Cosimelli M
Surg Oncol; 2020 Dec; 35():89-96. PubMed ID: 32858390
[TBL] [Abstract][Full Text] [Related]
19. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
[TBL] [Abstract][Full Text] [Related]
20. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer.
Kusters M; Dresen RC; Martijn H; Nieuwenhuijzen GA; van de Velde CJ; van den Berg HA; Beets-Tan RG; Rutten HJ
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1444-9. PubMed ID: 19395199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
